Data from mouse mammary tumor and human breast cancer models show that the ZMYND8 acting as histone reader was selectively expressed in breast cancer stem cells (BCSCs) and promotes epithelial-mesenchymal transition (EMT). This evidence concerns the gene ZMYND8 and breast cancer.